CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
CVI Accepts, published online ahead of print on 3 October 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00188-07v1
14/12/1603    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PETRAITYTE, R.
Right arrow Articles by SASNAUSKAS, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PETRAITYTE, R.
Right arrow Articles by SASNAUSKAS, K.

 Previous Article  |  Next Article 

Clin. Vaccine Immunol. doi:10.1128/CVI.00188-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Detection of Hantaan Virus-Specific IgG and IgM in Oral Fluid Using Yeast Expressed Recombinant Nucleocapsid Protein

RASA PETRAITYTE*, LI JIN, RASHPAL HUNJAN, AUSRA RAZANSKIENE, AURELIJA ZVIRBLIENE, and KESTUTIS SASNAUSKAS

Institute of Biotechnology, V.A. Graiciuno 8, LT-02241 Vilnius, Lithuania; Virus Reference division, Centre for infections, Health Protection Agency, Colindale, London, UK

* To whom correspondence should be addressed. Email: prasa{at}ibt.lt.


   Abstract

Hantaan virus is the causative agent of severe hemorrhagic fever with renal syndrome. Clinical surveillance of Hantaan virus infection is unreliable and laboratory verification is essential. The detection of virus-specific IgM/IgG in serum is most commonly used for the diagnosis of hantavirus infection. Testing of oral fluid samples instead of serum offers many advantages for surveillance. However, commercial tests for hantavirus-specific antibodies are unavailable. For the detection of Hantaan virus in oral fluid of humans, we have developed monoclonal antibody-based capture enzyme linked immunosorbent IgM assay (IgM capture ELISA) and indirect enzyme linked immunosorbent IgG/IgM assays (indirect IgG/IgM ELISA) for paired serum/oral fluid samples using yeast expressed nucleocapsid protein of Hantaan-Fojnica virus. The sensitivity and specificity of oral fluid IgM capture ELISA in comparison with the serum Hantaan IgM, were 96.7% and of 94.9%, respectively. Thus, data on the overall performance of oral fluid IgM capture ELISA is in close agreement with serum IgM assay, and exhibit a potential to serve as an easily transferable tool for large-scale epidemiological studies. Data on the indirect IgM ELISA showed also close agreement with serum IgM data, just the indirect IgG ELISA displayed the lower sensitivity and specificity. In conclusion, IgM capture ELISA can be used for diagnosis of Hantaan infection in oral fluid instead of serum samples.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.